RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
110 hedge funds and large institutions have $957M invested in Revance Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 24 closing their positions.
Holders
110
Holders Change
-10
Holders Change %
-8.33%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
47
Reduced
28
Closed
24
Calls
$2.94M
Puts
$2.19M
Net Calls
+$746K
Net Calls Change
-$1.04M
Top Buyers
1 |
1
Capital World Investors
Los Angeles,
California
|
$39.4M |
2 |
2
BlackRock
New York
|
$80.5M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$101M |
4 |
4
AllianceBernstein
Nashville,
Tennessee
|
$36M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$40.6M |